Medline Inc MDLN.OQ MDLN.O is expected to report resultson February 25 for the period ending December 31 2025
The Northfield Illinois-based company is expected to report revenue of $7.547 billion, according to the mean estimate from 22 analysts, based on LSEG data.
LSEG's mean analyst estimate for Medline Inc is for earnings of 25 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy".
Wall Street's median 12-month price target for Medline Inc is $48.00, about 3.6% below its last closing price of $49.80
This summary was machine generated February 23 at 13:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments